Association between Monocyte to High-Density Lipoprotein Cholesterol Ratio and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study

Table 5

Multivariable analysis for factors associated with NAFLD.

Variables	β	SE	Wald	value	OR	95% CI
Gender (male/female)	0.611	0.072	72.993	<0.001	1.843	1.602–2.121
Age (year)	0.006	0.002	5.921	0.015	1.006	1.001–1.011
BMI (kg/m^2)	0.228	0.016	214.860	<0.001	1.256	1.218–1.295
Waist circumference (cm)	0.070	0.006	153.006	<0.001	1.073	1.061–1.085
Diastolic blood pressure (mmHg)	0.013	0.002	28.945	<0.001	1.013	1.008–1.018
Alanine aminotransferase (U/L)	0.012	0.002	66.098	<0.001	1.012	1.009–1.015
Triglyceride (mmol/L)	0.428	0.030	202.356	<0.001	1.535	1.447–1.628
Total cholesterol (mmol/L)	0.100	0.031	10.742	0.001	1.105	1.041–1.174
Fasting plasma glucose (mmol/L)	0.264	0.025	108.257	<0.001	1.302	1.239–1.368
Serum uric acid (μmol/L)	0.004	0.000	114.931	<0.001	1.004	1.003–1.005
MHR	0.026	0.012	4.357	0.037	1.026	1.002–1.052

BMI: body mass index; β: partial regression coefficient; LDL-C: low-density lipoprotein cholesterol; MHR: monocyte to HDL-C ratio; NAFLD: nonalcoholic fatty liver disease; SE: standard error of partial regression coefficient.